OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Improving these processes involves adjusting various variables, including cell line development, media composition, and bioreactor settings. A key goal is to increase antibody yield while reducing production financial